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Toxocara canis-associated visceral larva migrans of the liver
Figure 3. Histological examination of the ultrasound-guided liver biopsy specimen
revealed granulomatous inﬂammation with extensive inﬁltration of eosinophils.
The remnants of Toxocara canis larvae were not identiﬁed; they can seldom be
captured by percutaneous biopsy. Hematoxylin-eosin staining.
Figure 2. At the initial evaluation, there were multiple oval- or irregular-shaped
low-attenuating nodules scattered along the portal veins. They were dominantly
located in the subcapsular area. Hepatobiliary phase sequence of the enhanced MRI
using hepatocyte-speciﬁc agent of Gd-EOB-DTPA.
Figure 1. Hepatic ultrasonography showed ill-deﬁned hypoechoic nodules of
approximately 10 mm in diameter (arrows).
Figure 4. 6 months after the treatment, the lesions had almost disappeared and only
a few scars were persistent. Hepatobiliary phase sequence of the enhanced MRI
using Gd-EOB-DTPA.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idA 68-year-old man was referred to our hospital for evaluation of
asymptomatic hypereosinophilia; the peripheral eosinophil count
was 6,365/mL. Raw cattle liver was his peculiar tonic. Hepatic
ultrasonography showed ill-deﬁned hypoechoic nodules (Fig. 1).
The lesions were most clearly depicted on enhanced MRI using ahttp://dx.doi.org/10.1016/j.ijid.2014.11.012
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).hepatocyte-speciﬁc agent (Fig. 2).1 Histological examination of the
liver biopsy specimen revealed eosinophilic granulomatous
inﬂammation (Fig. 3). An enzyme-linked immunosorbent assay
using Toxocara canis excretory-secretory antigens had conﬁrmed
its infestation.2 6 months after the administration of albendazole,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
/ International Journal of Infectious Diseases 30 (2015) 148–149 149the peripheral eosinophil count was reduced to 400/mL. Enhanced
MRI showed that the hepatic lesions had almost disappeared
(Fig. 4). Although humans are not deﬁnitive hosts of dog
roundworm Toxocara canis, exceptional transmissions to humans
are possible from raw meat contaminated with the embryonated
eggs.3 The larvae hatch in the intestine, travel to the liver via portal
vein, and remain in the parenchyma, causing visceral larva
migrans.4 Resultant hepatic lesions are usually recognized on
the portal venous phase of enhanced CT or MRI using extracellular
agents3. However, their imaging ﬁndings are rather nonspeciﬁc
and the lesions with subtle attenuation differences are difﬁcult
to deﬁne.5 Enhanced MRI using a hepatocyte-speciﬁc agent has a
distinct advantage for detecting hepatic visceral larva migrans and
judging their resolution over the therapeutic course1.
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